Advanced search
Publication Cover
Journal of Asthma Volume 59, 2022 - Issue 9
Submit an article Journal homepage
6,111
Views
3
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study

Carlyne M. Averella US Value, Evidence and Outcomes, GlaxoSmithKline plc., NC, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2098-2841
, MS, SMORCID Icon,
François Lalibertéb Health Economics and Outcomes Research, Groupe d’analyses, Ltée, Montréal, QC, CanadaORCID Iconhttps://orcid.org/0000-0003-2601-6214
, MAORCID Icon,
Guillaume Germainb Health Economics and Outcomes Research, Groupe d’analyses, Ltée, Montréal, QC, Canada
, MSc,
Mei Sheng Duhc Health Economics and Outcomes Research, Analysis Group, Inc., Boston, MA, USA
, Scd,
Robson Limad US Medical Affairs, GlaxoSmithKline plc., NC, USA
, MD,
Malena Mahendranb Health Economics and Outcomes Research, Groupe d’analyses, Ltée, Montréal, QC, Canada
, MSc &
David J. Sladee Clinical Sciences, GlaxoSmithKline plc., NC, USA
, MD show all
Pages 1805-1818 | Received 15 Mar 2021, Accepted 29 Jul 2021, Published online: 25 Aug 2021

Related Research Data

Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.